Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02482389 · ClinicalTrials.gov registry record · NA
Study of Preoperative Boost Radiotherapy
A NA study, sponsored by Duke University.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT02482389: Clinical Trial NA study, sponsored by Duke University.
NCT02482389 is a NA study that was terminated before completion, run by Duke University. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02482389, a NA study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This protocol seeks to utilize a novel method of tumor bed boost delivery and to better understand breast cancer radiation response through the analysis of pre-and post-radiation breast tumor samples.
Primary Outcome
Change from baseline rates of cosmesis at 3 years post-treatment as measured by the NRG Oncology cosmesis scale. The scale is scored from 1 (excellent) to 4 (poor) with a lower number representing better physical appearance.
Interventions
- RADIATION Single fraction of 7 Gy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2015-09-08 |
| Est. Completion | 2021-06-25 |
| Phase | NA |
Why NCT02482389 stopped before completion
NCT02482389 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Single fraction of 7 Gy is the first listed.
NCT02482389 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02482389 about?
NCT02482389 is a clinical study titled "Study of Preoperative Boost Radiotherapy". This protocol seeks to utilize a novel method of tumor bed boost delivery and to better understand breast cancer radiation response through the analysis of pre-and post-radiation breast tumor samples.
What is the current status of trial NCT02482389?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2015-09-08. Estimated completion is 2021-06-25.
What interventions are being tested in trial NCT02482389?
The interventions under investigation include: Single fraction of 7 Gy (RADIATION).
Who is sponsoring clinical trial NCT02482389?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02482389's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI